Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19

A DNA based vaccine against COVIDПодробнее

First Congress, 2-Scientific Session One Part 1Подробнее

Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of YearПодробнее

Kate E. Broderick| Inovio Pharmaceuticals| USA | Vaccines 2014 | OMICS InternationalПодробнее

Advantages of DNA Vaccines in Response to the COVID-19 OutbreakПодробнее

INO-4800 vaccine starts clinical trials in S. Korea -- WHO expert explains how it worksПодробнее

Kate Broderick, Ph.D.Подробнее

INOVIO's Dr. Kate Broderick Interview on Fox NewsПодробнее

COVID-19 Webinar on DNA vaccines --- Sponsored by Sino BiologicalПодробнее

Bill Gates funded vaccine INO-4800 for COVID19|DNA VACCINE FOR COVID-19|COVID19Подробнее

Promising results for InovioПодробнее

COVID-19 Vaccines: Your Questions AnsweredПодробнее

Kate Broderick, Inovio: 2-3 hours to design a Covid-19 VaccineПодробнее

Inovio’s COVID19 VaccineПодробнее

SARS CoV-2 Expert Symposium: Discussion Panel 2 with Alex Sette, Antonio Bertoletti, Kate BroderickПодробнее

San Diego company says it's on the road to developing a coronavirus vaccineПодробнее

INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccineПодробнее

How a Covid-19 Vaccine Human Trial WorksПодробнее

StaPH B Monthly Webinar April 2021Подробнее